Kui Wang Selected Research

bis(acetylacetonato)oxovanadium(IV)

11/2018	Vanadyl complexes discriminate between neuroblastoma cells and primary neurons by inducing cell-specific apoptotic pathways.
6/2013	Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.
8/2008	Vanadyl bisacetylacetonate induced G1/S cell cycle arrest via high-intensity ERK phosphorylation in HepG2 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kui Wang Research Topics

Disease

86	Neoplasms (Cancer) 01/2022 - 04/2002
30	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 05/2002
21	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 02/2011
14	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2006
10	Cholangiocarcinoma 01/2022 - 03/2013
8	Leukemia 01/2019 - 01/2005
6	Infections 04/2022 - 06/2007
6	Inflammation (Inflammations) 04/2022 - 03/2015
5	Breast Neoplasms (Breast Cancer) 12/2016 - 05/2013
4	Carcinogenesis 01/2022 - 12/2018
4	Glioma (Gliomas) 12/2021 - 05/2011
4	Hypoxia (Hypoxemia) 03/2021 - 09/2011
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 04/2014
4	Brain Neoplasms (Brain Tumor) 10/2017 - 10/2014
3	Transient Ischemic Attack 04/2022 - 01/2022
3	Margins of Excision 01/2021 - 05/2007
3	Alzheimer Disease (Alzheimer's Disease) 10/2020 - 01/2010
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 06/2011
3	Fibrosis (Cirrhosis) 01/2018 - 04/2015
3	Prostatic Neoplasms (Prostate Cancer) 10/2015 - 11/2011
3	Vascular Calcification 09/2007 - 12/2004
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 05/2017
2	Brain Injuries (Brain Injury) 01/2022 - 01/2018
2	Pain (Aches) 10/2021 - 08/2008
2	Reperfusion Injury 03/2021 - 05/2017
2	Obesity 01/2021 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2020 - 01/2016
2	Nephrogenic Fibrosing Dermopathy 01/2019 - 09/2010
2	Dyslipidemias (Dyslipidemia) 01/2019 - 12/2015
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2003
13	Pharmaceutical PreparationsIBA 12/2021 - 05/2011
12	Biological ProductsIBA 04/2021 - 07/2010
11	ChitosanIBA 12/2016 - 05/2013
9	EnzymesIBA 01/2022 - 08/2010
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 08/2010
7	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 02/2005
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
6	CytokinesIBA 10/2021 - 05/2013
6	Small Interfering RNA (siRNA)IBA 03/2021 - 01/2013
6	ChlorotoxinIBA 01/2019 - 02/2011
6	AlginatesIBA 10/2016 - 05/2013
5	AntigensIBA 01/2020 - 01/2010
5	arsenic disulfide (realgar)IBA 01/2009 - 01/2005
4	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
4	AntioxidantsIBA 01/2021 - 09/2010
4	GadoliniumIBA 01/2019 - 06/2009
4	LigandsIBA 01/2019 - 02/2011
4	Vanadium CompoundsIBA 11/2018 - 04/2010
4	Antiviral Agents (Antivirals)IBA 10/2018 - 03/2017
4	Peptides (Polypeptides)IBA 01/2016 - 02/2014
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2015 - 05/2007
3	Interleukin-33IBA 04/2022 - 01/2022
3	Therapeutic UsesIBA 12/2021 - 12/2016
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2021 - 09/2014
3	Fetal Proteins (Fetoprotein)IBA 07/2021 - 04/2016
3	Temozolomide (Temodar)FDA LinkGeneric 02/2021 - 10/2014
3	LipidsIBA 01/2021 - 09/2005
3	Tumor Biomarkers (Tumor Markers)IBA 12/2019 - 12/2012
3	Contrast MediaIBA 01/2019 - 09/2010
3	Annexin A2 (Annexin II)IBA 01/2019 - 07/2012
3	bis(acetylacetonato)oxovanadium(IV)IBA 11/2018 - 08/2008
3	CateninsIBA 01/2018 - 01/2013
3	Capsules (Microcapsules)IBA 04/2016 - 05/2007
3	oxidized low density lipoproteinIBA 01/2016 - 12/2015
3	arsenic trisulfide (orpiment)IBA 01/2009 - 11/2006
3	OxysterolsIBA 09/2007 - 12/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 05/2011
2	Oxygen (Dioxygen)IBA 01/2022 - 05/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 07/2014
2	CalciumIBA 01/2021 - 02/2016
2	Long Noncoding RNAIBA 01/2021 - 10/2020
2	LDL CholesterolIBA 01/2021 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2005
2	CarbohydratesIBA 01/2020 - 07/2017
2	Protein Kinases (Protein Kinase)IBA 01/2020 - 09/2010
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019 - 06/2014
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 10/2013
2	indium-bleomycinIBA 01/2019 - 01/2018
2	Vanadates (Orthovanadate)IBA 11/2018 - 02/2012
2	Nucleic AcidsIBA 10/2017 - 01/2017
2	Calcium Carbonate (Limestone)FDA Link 09/2017 - 11/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2017 - 05/2011
2	Alkaline PhosphataseIBA 07/2017 - 02/2016
2	Carcinoembryonic AntigenIBA 07/2017 - 03/2013
2	ErbB Receptors (EGF Receptor)IBA 06/2017 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 05/2017 - 01/2016
2	ChemokinesIBA 01/2017 - 02/2014
2	HydrogelsIBA 01/2017 - 07/2014
2	Sorafenib (BAY 43-9006)FDA Link 12/2016 - 02/2012

Therapy/Procedure

29	Therapeutics 12/2021 - 04/2002
23	Hepatectomy 01/2022 - 10/2012
7	Drug Therapy (Chemotherapy) 12/2021 - 05/2011
2	Photothermal Therapy 12/2021 - 11/2018
2	Oral Administration 10/2021 - 07/2006
2	Radiotherapy 10/2017 - 06/2015